NCT06270147 Timing of TAP Blocks in Bariatric Surgery
| NCT ID | NCT06270147 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | McMaster University |
| Condition | Opioid Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-11-21 |
| Primary Completion | 2025-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 100 participants in total. It began in 2024-11-21 with a primary completion date of 2025-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to determine the optimal timing for administering a Transversus Abdominis Plane (TAP) block in bariatric surgery, specifically investigating whether initiating TAP blocks at the beginning of surgery is more beneficial than at the end, which is the current practice. The study targets obese patients undergoing bariatric surgery, with a focus on reducing postoperative pain and opioid use. Key outcomes include recovery duration, pain levels, opioid consumption, and respiratory function. Successful results could establish early TAP block initiation as a standard practice, offering faster recovery, decreased opioid reliance, and reduced healthcare costs.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing primary bariatric surgery at St. Joseph's Healthcare Hamilton surgery including Sleeve Gastrectomy (SG) or Roux-en-Y Gastric Bypass Surgery (RYGB) * Patients \>18 Years of Age Exclusion Criteria: * Patients undergoing a revisional bariatric surgery * Patients with a history of chronic pain or opioid use.
Frequently Asked Questions
Who can join the NCT06270147 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06270147 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06270147 currently recruiting?
Yes, NCT06270147 is actively recruiting participants. Visit ClinicalTrials.gov or contact McMaster University to inquire about joining.
Where is the NCT06270147 trial being conducted?
This trial is being conducted at Hamilton, Canada.
Who is sponsoring the NCT06270147 clinical trial?
NCT06270147 is sponsored by McMaster University. The trial plans to enroll 100 participants.